Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a shareholder and consumer rights litigation firm, is investigating whether Corcept Therapeutics Incorporated (“Corcept” or the “Company”) (NASDAQ: CORT) or certain of its officers and directors issued misleading and false statements and/or failed to disclose information material to investors in violation of federal securities laws.
If you own Corcept common stock and have recently suffered financial losses, join our investigation on behalf of investors by filling out the form below.
On December 31, 2025, Corcept announced in a press release that the “U.S. Food and Drug Administration (FDA or the Agency) has issued a Complete Response Letter (CRL) regarding the New Drug Application (NDA) for relacorilant as a treatment for patients with hypertension secondary to hypercortisolism.” The Company stated in the press release that “the Agency concluded it could not arrive at a favorable benefit-risk assessment for relacorilant without Corcept providing additional evidence of effectiveness.”
Following this news, Corcept’s stock price fell more than 50%, to a closing price of $34.80 per share on December 31, 2025.
Corcept is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders.
If you have purchased Corcept common stock, and have suffered a loss, realized or unrealized, and you wish to discuss this investigation, please contact attorney Mandeep S. Minhas at (888) 398-9312 or at [email protected].
About this investigation – FAQ:
Q1: What is this ongoing investigation into Corcept Technologies about?
A: According to our investigation, owners of Corcept common stock have been impacted by a December 31, 2025, stock drop of 50% to a closing price of $34.80, potentially resulting in significant losses for investors.
Q2: How can this Scott+Scott investigation assist in recovering my assets?
A: Scott+Scott has a decades-long track record of prosecuting securities fraud litigation. Join our investigation now to learn if you have potential claims against Corcept Technologies Inc.
Q3: Is there any cost involved for me?
A: No, you can join our investigation or subsequent lawsuit at no cost for you. If you join, you may eventually be able to claim compensation for your financial losses.